The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-On Therapy to Metformin in Patients With Uncontrolled Type 2 Diabetes Mellitus
Diabetes Therapy - United States
doi 10.1007/s13300-016-0206-7
Full Text
Open PDFAbstract
Available in full text
Date
October 27, 2016
Authors
Publisher
Springer Science and Business Media LLC